Reveal Pharmaceuticals, Inc.
Cambridge, MA · Biotech · Private
RVP-001, a gadolinium-free manganese-based MRI contrast agent molecule
revealpharma.com →- Grants
- $5.4M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Manganese-based Contrast Agent for Cardiovascular MRI | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Manganese Based MRI Contrast Agent - First In Human Clinical Trial | $2,053,452 | |
| Federal grant | Department of Health and Human Services · Phase II · Manganese-based Contrast Agent for Cardiovascular MRI | $1,026,595 | |
| Federal grant | Department of Health and Human Services · Phase II · Manganese Based MRI Contrast Agent | $2,025,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1596 | Algen Biotechnologies Inc | — | — |
| 1597 | Novear Therapeutics LLC | — | — |
| 1598 | AVANT IMMUNOTHERAPEUTICS, INC. | — | — |
| 1599 | Reveal Pharmaceuticals, Inc. | — | — |
| 1600 | SYNACTIX PHARMACEUTICALS, INC. | — | — |
| 1601 | AllRock Bio | — | — |
| 1602 | TURTLETREE LABS INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.